U.K. Allows Supplement Weight-Loss Claims Little Wiggle Room
This article was originally published in The Tan Sheet
Executive Summary
As resolution season arrives, the advertising watchdog underscores the rules for weight-loss claims and testimonials. Boots Pharmaceuticals’ Carb Control made a common unsubstantiated diet aid claim – binding fats in the stomach so they are not absorbed by the body, helping users shed pounds, the agency says.
You may also be interested in...
Demand For “Prediabetes” Supplements Exposes Marketing Risks
Navigating legally among claims for prediabetes or blood sugar levels is tricky. Experts discuss what keeps a claim legal and what crosses the line, and spotlight other disease categories that can get firms in trouble if claims are not crafted properly.
In Rare Cannabinoids, BioMedican Sees Alphabet Of Potential Dietary And Drug Ingredients
BioMedican is ready to produce CBG, cannabigerol, and THC-V, tetrahydrocannabivarin, through biosynthesis and plans by the end of the year to start making CBN, cannabinol, and THC-A, tetrahydrocannabinolic-acid.
‘Pharmaceutical’ Controls, Lower Costs: Future Of Cannabinoid Ingredients In Biosynthesis?
Synthetics are necessary for drugs containing cannabinoids because the active ingredient must be consistent from dose to dose. Cannabinoids extracted from hemp vary from plant to plant and more widely from crop to crop, but consistency should matter for cannabinoids used as dietary ingredients, says BioMedican president Dennis O’Neill.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: